Genetic Technologies Limited
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinicall… Read more
Market Cap & Net Worth: Genetic Technologies Limited (GNTLF)
Genetic Technologies Limited (PINK:GNTLF) has a market capitalization of $145.42 Million ($145.42 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #30703 globally and #10111 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genetic Technologies Limited's stock price $1.00 by its total outstanding shares 145417246 (145.42 Million).
Genetic Technologies Limited Market Cap History: 2015 to 2025
Genetic Technologies Limited's market capitalization history from 2015 to 2025. Data shows growth from $298.11 Million to $145.42 Million (0.00% CAGR).
Genetic Technologies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genetic Technologies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.15x
Genetic Technologies Limited's market cap is 0.15 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $298.11 Million | $2.01 Million | -$8.81 Million | 148.17x | N/A |
| 2016 | $145.42 Million | $824.59K | -$8.46 Million | 176.35x | N/A |
| 2017 | $72.71 Million | $518.51K | -$8.40 Million | 140.23x | N/A |
| 2019 | $14.54 Million | $25.44K | -$6.43 Million | 571.52x | N/A |
| 2020 | $1.45 Million | $9.86K | -$6.10 Million | 147.42x | N/A |
| 2021 | $29.08 Million | $120.55K | -$7.08 Million | 241.25x | N/A |
| 2022 | $58.17 Million | $9.22 Million | -$7.13 Million | 6.31x | N/A |
| 2023 | $10.18 Million | $10.35 Million | -$11.75 Million | 0.98x | N/A |
| 2024 | $1.45 Million | $9.67 Million | -$12.02 Million | 0.15x | N/A |
Competitor Companies of GNTLF by Market Capitalization
Companies near Genetic Technologies Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Genetic Technologies Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Genetic Technologies Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Genetic Technologies Limited's market cap moved from $298.11 Million to $ 145.42 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $145.42 Million | +9900.00% |
| 2024 | $1.45 Million | -85.71% |
| 2023 | $10.18 Million | -82.50% |
| 2022 | $58.17 Million | +100.00% |
| 2021 | $29.08 Million | +1900.00% |
| 2020 | $1.45 Million | -90.00% |
| 2019 | $14.54 Million | -80.00% |
| 2017 | $72.71 Million | -50.00% |
| 2016 | $145.42 Million | -51.22% |
| 2015 | $298.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genetic Technologies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $145.42 Million USD |
| MoneyControl | $145.42 Million USD |
| MarketWatch | $145.42 Million USD |
| marketcap.company | $145.42 Million USD |
| Reuters | $145.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.